Fennec Pharmaceuticals

FENC

Börsenwert 409 Mio. $

#	Name	Position	Handelswert	Veränderung Aktien	Anteils- änderung
1	1 Southpoint Capital Advisors New York	38,2 Mio. $	–	–	–
2	2 Solas Capital Management Darien, Connecticut	20,5 Mio. $	-389.552 $	-45.000	-2 %
3	3 Rosalind Advisors Toronto, Ontario, Canada	19,4 Mio. $	+270.054 $	+31.196	+2 %
4	4 BlackRock New York	11,3 Mio. $	-126.656 $	-14.631	-1 %
5	5 Vanguard Group Malvern, Pennsylvania	8,95 Mio. $	-98.063 $	-11.328	-1 %
6	ACM 6 AIGH Capital Management Baltimore, Maryland	6,38 Mio. $	+1,98 Mio. $	+229.101	+51 %
7	7 State Street Boston, Massachusetts	3,19 Mio. $	+40.747 $	+4.707	+1 %
8	8 Tang Capital Management San Diego, California	3,13 Mio. $	+2,72 Mio. $	+314.066	+1.530 %
9	9 Geode Capital Management Boston, Massachusetts	2,82 Mio. $	-33.112 $	-3.825	-1 %
10	10 Morgan Stanley New York	2,18 Mio. $	-188.855 $	-21.816	-9 %
11	11 Harbert Fund Advisors Birmingham, Alabama	1,66 Mio. $	-950.497 $	-109.799	-38 %
12	GJL 12 Gendell Jeffrey L	1,31 Mio. $	-1.273 $	-147	-0,1 %
13	13 Northern Trust Chicago, Illinois	1,22 Mio. $	-7.956 $	-919	-0,7 %
14	LPC 14 Lion Point Capital New York	1,15 Mio. $	-629.342 $	-72.700	-37 %
15	15 Citadel Advisors Miami, Florida	1,01 Mio. $	+525.574 $	+60.713	+130 %
16	16 Jane Street New York	679.826 $	+196.005 $	+22.642	+45 %
17	17 Charles Schwab San Francisco, California	535.851 $	-34.956 $	-4.038	-7 %
18	18 Bank of New York Mellon New York	489.325 $	+4.034 $	+466	+0,9 %
19	19 Hartford Financial Management Hartford, Connecticut	474.047 $	–	–	–
20	20 RhumbLine Advisers Boston, Massachusetts	313.757 $	-3.246 $	-375	-1 %
21	21 Barclays London, United Kingdom	309.236 $	-60.311 $	-6.967	-17 %
22	22 State of Wisconsin Investment Board Madison, Wisconsin	300.456 $	+77.045 $	+8.900	+38 %
23	23 Bridgeway Capital Management Houston, Texas	287.352 $	+56.269 $	+6.500	+27 %
24	24 Arrowstreet Capital Boston, Massachusetts	253.235 $	–	–	–
25	25 Goldman Sachs New York	247.946 $	+91.345 $	+10.552	+66 %

Fennec Pharmaceuticals FENC Börsenwert 409 Mio. $

Fennec Pharmaceuticals

FENC

Börsenwert 409 Mio. $